Latest Financial Results

Q1 FY27

Quarter Ended Sep 30, 2026

View All Financial Results

Latest News

Latest Presentation

Q1 FY27 Earnings Presentation View Quarterly Presentation

Upcoming Event

2026 Virtual Annual Stockholders Meeting
Add To Calendar View Events

Highlights

  • Target markets are very large and significantly underpenetrated.
  • Resmed is well-positioned with differentiated products, a robust innovation pipeline, and supply chain flexibility.
  • Key mega trends in big tech and pharma are driving patients to our sleep ecosystem.
  • Strong revenue growth and operating leverage delivered a year-over-year growth in free cash flow.
  • Balance sheet is very strong.
  • Experienced management team has successfully delivered long-term growth and navigated externalities including COVID, supply chain perturbations, and 5-year exit of a peer from US device market.
  • Industry advocacy via AdvaMed volunteer chairman and other team leadership roles.
  • Strong brand built through high-quality products and customer service levels has supported Resmed's market-leading position.

IR Contacts

Headquarters

ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123

Investor Relations

ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123
Phone: 858-221-3304
InvestorRelations@resmed.com

Transfer Agent

Computershare, Inc.
PO Box 30170
College Station, TX 77842
USA
Phone: 800-962-4284
https://www.computershare.com/us

Computershare, Inc.
Level 3
60 Carrington Street
Sydney NSW 2000
Australia
Phone: +61 2 8234 5000
https://www.computershare.com/au